Similar articles

• High-dose therapy in breast cancer: out of favor but not out of promise.

  Glück S, Stewart D. Glück S, et al. Bone Marrow Transplant. 2000 May;25(10):1017-9. doi: 10.1038/sj.bmt.1702388. Bone Marrow Transplant. 2000. PMID: 10828859
• High-dose chemotherapy with autologous bone marrow transplantation for the treatment of breast cancer: yes.

  Peters WP. Peters WP. Important Adv Oncol. 1995:215-30. Important Adv Oncol. 1995. PMID: 7672808 Review. No abstract available.
• [Autologous hematopoietic stem cell transplantation for the treatment of breast cancer].

  Mukaiyama T, Okamoto R, Sasaki T. Mukaiyama T, et al. Gan To Kagaku Ryoho. 1995 Oct;22(12):1731-40. Gan To Kagaku Ryoho. 1995. PMID: 7574803 Review. Japanese.
• [Consolidation radiotherapy after high-dose chemotherapy and autologous bone marrow transplantation in patients with advanced breast cancer].

  Rühl U. Rühl U. Strahlenther Onkol. 2000 Apr;176(4):196-7. Strahlenther Onkol. 2000. PMID: 10812394 Clinical Trial. German. No abstract available.
• Quality of life among patients with Stage II and III breast carcinoma randomized to receive high-dose chemotherapy with autologous bone marrow support or intermediate-dose chemotherapy: results from Cancer and Leukemia Group B 9066.

  Peppercorn J, Herndon J 2nd, Kornblith AB, Peters W, Ahles T, Vredenburgh J, Schwartz G, Shpall E, Hurd DD, Holland J, Winer E. Peppercorn J, et al. Cancer. 2005 Oct 15;104(8):1580-9. doi: 10.1002/cncr.21363. Cancer. 2005. PMID: 16118805 Clinical Trial.